Peterson E M, Cheng X, Qu Z, de La Maza L M
University of California, Irvine 92717-4800, USA.
Infect Immun. 1996 Aug;64(8):3354-9. doi: 10.1128/iai.64.8.3354-3359.1996.
In an attempt to gain more knowledge about the immunogenicity of the variable domains (VDs) of the major outer membrane protein (MOMP) of Chlamydia pneumoniae, peptides representing these areas were used to immunize BALB/c and C57BL/6 mice. Antisera to the peptides and to peptides conjugated to keyhole limpet hemocyanin (KLH) were characterized by their ability to recognize the immunizing peptide and elementary bodies (EBs) of C. pneumoniae by enzyme-linked immunosorbent assay (ELISA) and Western blot (immunoblot). In addition, antiserum was analyzed for its molecular specificity by a pepscan as well as its in vitro neutralizing ability. In general, results obtained with antisera to the peptides paralleled the results obtained with the antisera to the KLH-conjugated peptides except that the titers or strength of reaction in the assays was less. Antisera to the VDs in both strains of mice gave ELISA titers to the homologous VD peptide ranging from 1,000 to >64,000. The strength of reactivity with the reduced MOMP as judged by Western blot, in most cases, paralleled the ELISA titer to the peptide. However, only antisera raised in both strains of mice to the VD1 and VD4 peptides reacted strongly with the EBs, suggesting surface exposure of these VDs. In addition, antisera to VD3 from C57BL/6 mice gave strong reactivity to EBs. By pepscan analysis antisera from both strains of mice reacted with several VD1 and VD3 octameric peptides, with weaker reactivity being seen with the octameric peptides in the other two VDs. This was in contrast to antisera raised to EBs of C. pneumoniae TW-183, which identified two immunogenic regions, one in VD1 and the other mapped to VD4. While antisera raised to EBs strongly neutralized the infectivity of C. pneumoniae, none of the peptide antisera was able to neutralize. In addition, peptides to the VDs were not able to block the neutralizing ability of the antisera to EBs of C. pneumoniae. Therefore, these results suggest that the VDs of the MOMP of C. pneumoniae are surface exposed but do not elicit neutralizing antibodies when linear peptides representing them are used as the immunogen.
为了更多地了解肺炎衣原体主要外膜蛋白(MOMP)可变区(VDs)的免疫原性,用代表这些区域的肽免疫BALB/c和C57BL/6小鼠。通过酶联免疫吸附测定(ELISA)和蛋白质印迹法(免疫印迹),以识别免疫肽和肺炎衣原体原体(EBs)的能力来表征针对这些肽以及与钥孔血蓝蛋白(KLH)偶联的肽的抗血清。此外,通过肽扫描分析抗血清的分子特异性及其体外中和能力。总体而言,针对肽的抗血清所获得的结果与针对KLH偶联肽的抗血清所获得的结果相似,只是测定中的滴度或反应强度较低。两种小鼠品系中针对VDs的抗血清对同源VD肽的ELISA滴度范围为1000至>64000。在大多数情况下,通过蛋白质印迹判断与还原的MOMP的反应强度与针对该肽的ELISA滴度相似。然而,只有两种小鼠品系中针对VD1和VD4肽产生的抗血清与EBs强烈反应,表明这些VDs暴露于表面。此外,C57BL/6小鼠针对VD3的抗血清对EBs有强烈反应。通过肽扫描分析,两种小鼠品系的抗血清都与几种VD1和VD3八聚体肽反应,而在其他两个VDs中的八聚体肽反应较弱。这与针对肺炎衣原体TW-183的EBs产生的抗血清形成对比,后者识别出两个免疫原性区域,一个在VD1中,另一个定位在VD4中。虽然针对EBs产生的抗血清强烈中和肺炎衣原体的感染性,但没有一种肽抗血清能够中和。此外,针对VDs的肽不能阻断抗血清对肺炎衣原体EBs的中和能力。因此,这些结果表明肺炎衣原体MOMP的VDs暴露于表面,但当使用代表它们的线性肽作为免疫原时不会引发中和抗体。